Literature DB >> 21469126

Human plasmacytoid dendritic cells induce CD8⁺ LAG-3⁺ Foxp3⁺ CTLA-4⁺ regulatory T cells that suppress allo-reactive memory T cells.

Patrick P C Boor1, Herold J Metselaar, Sarina de Jonge, Shanta Mancham, Luc J W van der Laan, Jaap Kwekkeboom.   

Abstract

Allo-reactive memory T cells are a major barrier for induction of immunological tolerance to allografts in humans. Here, we report that stimulation of unfractionated human T cells with TLR-stimulated allogeneic plasmacytoid dendritic cells (pDCs) induces CD8(+) regulatory T cells (Tregs) that inhibit T-cell allo-responses, including those of memory T cells. CD3(+) T cells were primed for 7 days with allogeneic pDCs that had been pre-stimulated with TLR-7 or TLR-9 ligands. While the T cells proliferated and produced cytokines during the priming culture, they were profoundly hypo-responsive to re-stimulation with the same allo-antigen in a second culture. Moreover, T cells primed by pDCs exerted donor-specific suppression on allo-responses of both unfractionated and memory CD3(+) T cells. The regulatory capacity of pDC-primed T cells was confined to CD8(+) LAG-3(+) Foxp3(+) CTLA-4(+) T cells, which suppressed allogeneic T-cell responses through a CTLA-4-dependent mechanism. Induction of CD8(+) Tregs by pDCs could be partially prevented by 1-methyl tryptophan, an inhibitor of indoleamine 2,3-dioxygenase. In conclusion, stimulation of human T cells by TLR-stimulated allogeneic pDCs induces CD8(+) Tregs that inhibit allogeneic T-cell responses, including memory T cells. Donor-derived pDCs may be considered as an immunotherapeutic tool to prevent activation of the recipient allo-reactive (memory) T-cell repertoire after allogeneic transplantation.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21469126     DOI: 10.1002/eji.201041229

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  26 in total

1.  In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients.

Authors:  Séverine Bézie; Claire Usal; Carole Guillonneau
Journal:  J Vis Exp       Date:  2017-08-12       Impact factor: 1.355

Review 2.  Foxp3, Regulatory T Cell, and Autoimmune Diseases.

Authors:  Jin-Hui Tao; Miao Cheng; Jiang-Ping Tang; Qin Liu; Fan Pan; Xiang-Pei Li
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

Review 3.  Tolerogenic dendritic cells and their role in transplantation.

Authors:  Mohamed Ezzelarab; Angus W Thomson
Journal:  Semin Immunol       Date:  2011-07-07       Impact factor: 11.130

4.  Gene expression profiling of CD8+ T cells induced by ovarian cancer cells suggests a possible mechanism for CD8+ Treg cell production.

Authors:  Meng Wu; Jianfang Lou; Shuping Zhang; Xian Chen; Lei Huang; Ruihong Sun; Peijun Huang; Shiyang Pan; Fang Wang
Journal:  Cell Prolif       Date:  2016-09-19       Impact factor: 6.831

5.  Donor-specific CD8+ Foxp3+ T cells protect skin allografts and facilitate induction of conventional CD4+ Foxp3+ regulatory T cells.

Authors:  N M Lerret; J L Houlihan; T Kheradmand; K L Pothoven; Z J Zhang; X Luo
Journal:  Am J Transplant       Date:  2012-06-08       Impact factor: 8.086

Review 6.  Advances on Non-CD4 + Foxp3+ T Regulatory Cells: CD8+, Type 1, and Double Negative T Regulatory Cells in Organ Transplantation.

Authors:  Ann J Ligocki; Jerry Y Niederkorn
Journal:  Transplantation       Date:  2015-08       Impact factor: 4.939

Review 7.  CD8 T cells and Mycobacterium tuberculosis infection.

Authors:  Philana Ling Lin; JoAnne L Flynn
Journal:  Semin Immunopathol       Date:  2015-04-28       Impact factor: 9.623

8.  High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway.

Authors:  Claudia Volpi; Francesca Fallarino; Maria T Pallotta; Roberta Bianchi; Carmine Vacca; Maria L Belladonna; Ciriana Orabona; Antonella De Luca; Louis Boon; Luigina Romani; Ursula Grohmann; Paolo Puccetti
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

9.  Rapamycin has suppressive and stimulatory effects on human plasmacytoid dendritic cell functions.

Authors:  P P C Boor; H J Metselaar; S Mancham; L J W van der Laan; J Kwekkeboom
Journal:  Clin Exp Immunol       Date:  2013-12       Impact factor: 4.330

Review 10.  Role of plasmacytoid dendritic cell subsets in allergic asthma.

Authors:  H Maazi; J Lam; V Lombardi; O Akbari
Journal:  Allergy       Date:  2013-05-11       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.